# UNFOLDED_PROTEIN_BINDING Project: Complete Inquiry History

## Complete Project History with User Requests

### **Phase 1: Project Initialization & Documentation Updates**
- **Date**: February 20, 2026
- **User Request**: (Initial context - already had GO:0140309 rename confirmed)
- **Actions**:
  - Updated UNFOLDED_PROTEIN_BINDING.md with official date
  - Fixed GO:0140309 labels in spreadsheet
  - Converted 18+ retention entries to GO:0140309 recommendations
- **Progress**: 197/266 (74.1%)

---

### **Phase 2: Manual PMID Analysis**
- **User Request**: *(Implicit - work on completing the annotation review)*
- **Actions**:
  - Analyzed 11 available publications with detailed reviews
  - Created UNREVIEWED_ANNOTATIONS_ANALYSIS.md
  - Applied recommendations for AIPL1, cct_yeast, HSPA5, etc.
  - Created update_from_analysis.py script
- **Progress**: 197/266 → 207/266 (77.8%)

---

### **Phase 3: AI Review File Creation**
- **User Request**: *(Asked about "(No review file)" entries in the spreadsheet)*
- **User chose**: "Option B first" to use fill scripts
- **Actions**:
  - Created `/tmp/create_review_stubs.py`
  - Generated stub YAML files for 50+ genes
- **Result**: Enabled processing of genes without existing reviews

---

### **Phase 4: Inference-Based Recommendations**
- **User Request**: *(Continuation of Phase 3 - applying inference to new review files)*
- **Actions**:
  - Created and executed `infer_no_review_file.py`
  - Applied evidence-based inference scoring to 54 entries
- **Progress**: 207/266 → 261/266 (98.1%)

---

### **Phase 5: Final Complex Entries**
- **User Request**: *(Continuing to resolve remaining incomplete entries)*
- **Actions**:
  - Manual PMID analysis for protein complexes
  - Created and executed `finalize_last_5.py`
  - Handled naca-btf3_human, egd1-egd2_yeast, SSB1, HSP17.6A, GIP1
- **Progress**: 261/266 → 266/266 (100%)

---

### **Phase 6: ACCEPT Entries Issue Discovery & Fix**
- **User Request**: **"What is the meaning of ACCEPT? The existing annotation is to terms that will be obsoleted thus reannotation is necessary"**
- **Key Insight**: User identified that ACCEPT is insufficient - obsolete terms need specific replacements
- **Agent Response**: "You're absolutely right. All the ACCEPT entries still have the old obsolete terms and need specific replacement GO terms. Would you like me to go through all 32 ACCEPT entries and assign specific GO terms?"
- **User**: (Confirmed yes)
- **Actions**:
  - Created `fix_accept_entries.py` with protein classification logic
  - Updated all 32 ACCEPT entries with GO:0044183 or GO:0140309
- **Progress**: 198/266 with GO terms (74.4%)

---

### **Phase 7: Comprehensive Explanations**
- **User Request**: **"For all rows that don't have a recommended GO term annotation, provide explanation for the suggested action. For example, why suggest DELETE? Append explanations in column A."**
- **Actions**:
  - Created `add_explanations.py`
  - Added detailed rationales for 41 rows:
    - DELETE (5) with specific reasons
    - REVIEW (37) categorized by function type
- **Result**: All 266 annotations have complete justifications

---

## Recent Session: Deep Dive Analysis & Clarifications

### **HRD1/SYVN1 Investigation**
- **User Request**: **"Is HRD1 interaction with unfolded protein specific? That is, does HRD1 interact with just unfolded pael-r or other proteins as well?"**
- **Findings**: HRD1 is promiscuous E3 ligase; uses adapter proteins for substrate recognition
- **User Follow-up**: **"If it doesn't bind unfolded proteins directly, what mediates the binding?"**
- **Answer**: Multi-protein ERAD complex (Derlins, SEL1L, VIMP, p97)
- **Key Finding**: 
  - Derlins form membrane channels/dislocation ports
  - SEL1L acts as scaffolding/co-factor
  - VIMP is ER membrane receptor for p97
  - p97 provides energy for substrate extraction

---

### **Derlin Classification**
- **User Request**: **"Is derlins a holdase?"**
- **Answer**: NO - Derlins are membrane dislocation factors, not chaperones
- **Distinction**:
  - Holdases: Stabilize unfolded proteins for refolding
  - Derlins: Transport misfolded proteins for degradation (ERAD pathway)

---

### **HSPA1A Annotation Analysis**
- **User Request**: **"Explain the suggested action of gene HSPA1A based on the reference PMID:21909508."**
- **Analysis**: 
  - Paper: Chakrabortee et al., 2012 - "Intrinsically disordered proteins as molecular shields"
  - Shows HSP70 as classical chaperone vs. LEA proteins as molecular shields
  - HSP70: tight binding, heat stress response, structured domains
  - LEA: loose binding, desiccation stress, disordered proteins
- **User Follow-up**: **"Did this paper assay for ATP-dependency or that's inferred from general knowledge?"**
- **Answer**: Inferred from general knowledge, NOT directly assayed in this paper
  - Paper tested: aggregation assays, co-immunoprecipitation, FRET
  - Did NOT test: ATP inhibitors, ATPase-deficient mutants, ATP hydrolysis
- **User Follow-up**: **"Is the information presented in this paper sufficient to distinguish between GO:0044183 (protein folding chaperone) and GO:0140309 (unfolded protein holdase activity)?"**
- **Answer**: NO - paper doesn't distinguish between:
  - ATP-dependent refolding (GO:0044183)
  - ATP-independent stabilization (GO:0140309)
  - Whether binding leads to refolding or just prevents aggregation

---

### **HSP70 Multifunctionality**
- **User Request**: **"In the general literature, can HSP80 have holdase activity?"** *(Note: User typed "HSP80" but meant HSP70)*
- **Answer**: YES - HSP70 is multifunctional with BOTH activities:
  1. Primary role: ATP-dependent foldase/refoldase (GO:0044183)
     - Uses ATP hydrolysis to actively refold
     - Disaggregates protein aggregates
     - Delivers clients to other chaperones
  2. Secondary role: ATP-independent holdase (GO:0140309)
     - Binds and stabilizes partially folded intermediates
     - Prevents aggregation through binding alone
- **Implication**: HSP70 could legitimately annotate to BOTH GO terms
- **Challenge**: Single GO term annotations may be incomplete for multifunctional proteins

---

### **GO Terms Comprehensive Review**
- **User Request**: **"What are the different GO terms recommended in column A?"**
- **First Output**: Listed 10 GO terms with counts
- **User Correction**: **"GO:0051083 is not Chaperone binding."**
- **Correction Applied**: GO:0051083 = "'de novo' cotranslational protein folding"
- **User Request**: **"I need an accurate list of GO terms suggested for reannotation."**

#### Final Accurate List:

1. **GO:0044183: protein folding chaperone** [127 annotations]
   - ATP-dependent chaperones that actively refold misfolded proteins
   - Examples: HSPA1A, HSPH1, CALR, TSA1, tigA

2. **GO:0140309: unfolded protein holdase activity** [35 annotations]
   - ATP-independent chaperones that stabilize unfolded proteins
   - Examples: hsp22, Skp, lsc_yeast

3. **GO:0140662: ATP-dependent protein folding chaperone** [15 annotations]
   - Prokaryotic ATP-dependent chaperones (GroEL/DnaK family)
   - Examples: DnaK, GroEL, Hsp83

4. **GO:0140597: protein carrier chaperone** [11 annotations]
   - Chaperones involved in protein transport/delivery
   - Examples: SHQ1, YAR1, GET3, ACL4

5. **GO:0051083: 'de novo' cotranslational protein folding** [3 annotations]
   - Ribosome-associated chaperones during translation
   - Examples: BTT1, EGD1, EGD2

6. **GO:0051787: misfolded protein binding** [3 annotations]
   - Direct binding of misfolded proteins
   - Examples: SAN1, Nmnat

7. **GO:0140545: ATP-dependent protein disaggregase activity** [1 annotation]
   - Chaperones that break apart protein aggregates
   - Example: HSP104

8. **GO:0000511: H2A-H2B histone complex chaperone activity** [1 annotation]
   - Histone chaperones
   - Example: NAP1

9. **GO:0140318: protein transporter activity** [1 annotation]
   - ER/secretory pathway transporter
   - Example: SCG5

10. **GO:0070492: oligosaccharide binding** [1 annotation]
    - Sugar binding (likely lectins in ERAD)
    - Example: Fbxo2

---

### **Evidence Code Clarification**
- **User Request**: **"In the case of row 14 in the annotation review table, for the SSC1 gene, the suggested action is 'MARK_AS_OVER_ANNOTATED (Candida Genome Database, but NAS is computational)'. Why did you say NAS is computational?"**
- **Agent Response**: Acknowledged error and provided correction
- **Clarification**:
  - **NAS (Non-traceable Author Statement)** = unsupported claim in publication
    - Author makes claim without citing source
    - Cannot be traced to primary experimental evidence
    - Secondary assertion without direct support
  - **NOT computational** (that would be IEA or ISS)
  - Better explanation: "unsupported - annotation claim cannot be traced to experimental data or cited source"
- **Lesson**: NAS is low confidence due to lack of traceability, not because it's computational

---

### **Project Documentation Requests**
- **User Request**: **"Can I get a history of conversations?"**
- **Agent**: Provided recent session summary
- **User Request**: **"From all sessions concerning this project."**
- **Agent**: Provided comprehensive project history
- **User Request**: **"Can you include the record of what I asked for each of phases?"**
- **Agent**: Added user requests to history
- **User Request**: **"Save to a file, file name 'project_inquiry_history'"**
- **Current Action**: Creating this document

---

## Project Statistics (Current State)

**Total Annotations**: 266

### GO Term Annotations (198 = 74.4%)
- **GO:0044183**: 127 (protein folding chaperone - ATP-dependent)
- **GO:0140309**: 35 (unfolded protein holdase - ATP-independent)
- **Other GO terms**: 36
  - GO:0140662: 15 (ATP-dependent protein folding chaperone)
  - GO:0140597: 11 (protein carrier chaperone)
  - GO:0051083: 3 ('de novo' cotranslational protein folding)
  - GO:0051787: 3 (misfolded protein binding)
  - GO:0000511: 1 (H2A-H2B histone chaperone)
  - GO:0070492: 1 (oligosaccharide binding)
  - GO:0140318: 1 (protein transporter activity)
  - GO:0140545: 1 (ATP-dependent protein disaggregase)

### Non-GO Recommendations (68 = 25.6%)
- **REVIEW**: 37 (requires expert evaluation)
- **MARK_AS_OVER_ANNOTATED**: 22 (low confidence predictions)
- **DELETE**: 5 (false annotations - not chaperones)
- **UNDECIDED**: 1 (GIP1 - requires expert input)
- **MODIFY**: 1
- **NTR**: 1 (new term request)

**Completion**: 100% with recommendations and justifications

---

## Key User-Identified Issues & Corrections

1. **ACCEPT entries were insufficient** - needed specific replacement GO terms (Phase 6)
   - User insight: Obsolete terms require specific replacements, not generic "ACCEPT"
   
2. **Missing explanations** - non-GO recommendations needed justification (Phase 7)
   - User requested detailed rationales for DELETE, REVIEW, etc.

3. **GO:0051083 mislabeled** - corrected term definition
   - Agent error: Called it "chaperone binding"
   - Correct: "'de novo' cotranslational protein folding"

4. **NAS evidence code mischaracterized** - corrected as "unsupported" not "computational"
   - Agent error: Called NAS "computational"
   - Correct: NAS = Non-traceable Author Statement (unsupported claim)

5. **ATP-dependency assumptions** - many annotations rely on general knowledge
   - Specific papers may not directly test ATP requirements
   - GO term assignments sometimes inferred rather than demonstrated

---

## Key Methodological Insights Developed

### Evidence Quality Hierarchy
1. **High confidence**: IDA (Direct Assay), IMP (Mutant Phenotype), TAS (Traceable Author Statement)
2. **Medium confidence**: IPI (Physical Interaction), IGI (Genetic Interaction)
3. **Low confidence**: NAS (Non-traceable), IEA (Electronic Annotation), ISS (Sequence Similarity)

### Source Reliability Assessment
- **Most reliable**: Expert databases (MGI, SGD, UniProt, PomBase)
- **Moderate**: Community annotations (TAIR, ComplexPortal)
- **Least reliable**: Automated predictions (CAFA)

### Protein Function Classification Logic
- **Small HSPs** (hsp16, hsp22, HSP17.6A) → GO:0140309 (ATP-independent holdase)
- **HSP90 family** → GO:0044183 (ATP-dependent, despite size name)
- **CCT/TRiC, HSP70, DnaJ** → GO:0044183 (ATP-dependent)
- **ER chaperones** (CALR, CANX, CLGN) → GO:0044183
- **Tubulin cofactors, peptidyl-prolyl isomerases** → GO:0044183

### ERAD Components (NOT Chaperones)
- **E3 ubiquitin ligases** (HRD1/SYVN1) - tag proteins for degradation
- **ER lectins** (ERLEC1) - recognize glycans, not chaperone function
- **Dislocation factors** (Derlins) - membrane channels for ERAD
- **Nucleotide exchange factors** (GRPEL1) - regulate chaperones, not chaperones themselves

### Multifunctional Proteins Challenge
- Some proteins (e.g., HSP70) have BOTH foldase AND holdase activities
- Single GO term annotations may be incomplete
- May warrant dual annotations in some cases

---

## Outstanding Questions & Limitations

1. **MARK_AS_OVER_ANNOTATED entries (22)** could benefit from expert review
   - Low confidence computational predictions
   - May be false positives

2. **GIP1 remains UNDECIDED** - requires botanical expertise
   - Arabidopsis protein with unclear function

3. **ATP-dependency often inferred** rather than experimentally demonstrated in citing papers
   - Many GO term assignments based on general knowledge
   - May not meet strict experimental evidence standards

4. **Multifunctional proteins** (e.g., HSP70) may warrant dual GO term annotations
   - Current system uses single primary function
   - May miss secondary activities

5. **REVIEW entries (37)** require domain expert evaluation
   - Assembly chaperones with specific substrates
   - ER quality control proteins
   - Peptidyl-prolyl isomerases
   - Stress sensors vs. true chaperones

---

## Files Generated During Project

### Phase 2
- `update_from_analysis.py` - Applied manual PMID analysis recommendations
- `UNREVIEWED_ANNOTATIONS_ANALYSIS.md` - Detailed analysis of 11 publications

### Phase 3
- `/tmp/create_review_stubs.py` - Generated AI review stub YAML files
- 50+ YAML stub files in genes/ directory

### Phase 4
- `infer_no_review_file.py` - Applied evidence-based inference scoring

### Phase 5
- `finalize_last_5.py` - Handled complex protein entries

### Phase 6
- `fix_accept_entries.py` - Assigned specific GO terms to ACCEPT entries

### Phase 7
- `add_explanations.py` - Added explanations for non-GO recommendations

### Documentation
- `CURATION_PROGRESS.md` - Progress tracking through phases
- `NEXT_PHASE_PLAN.md` - Planning for remaining work
- `project_inquiry_history.md` - This document

---

## Git Commit History (8 Major Commits)

1. `fffa487d` - Update UNFOLDED_PROTEIN_BINDING: GO:0140309 confirmed
2. `1bc4b125` - Update GO:0140309 official rename to Feb 20, 2026
3. `92af7594` - Complete analysis of 8 additional publications (207/266)
4. `9aafb025` - Add curation progress documentation
5. `c3319847` - Create AI review stubs; apply inference (261/266)
6. `20de5abe` - Complete final 5 complex entries (266/266)
7. `6b1ee936` - Update CURATION_PROGRESS.md to reflect 100% completion
8. `c47054ed` - Fix all 32 ACCEPT entries with specific GO terms
9. `be1848d7` - Add explanations for all 68 non-GO recommendations

---

## Project Success Metrics

✅ **100% annotation coverage** (266/266)
✅ **74.4% with specific GO term assignments** (198/266) - exceeds 70% target
✅ **Zero generic "ACCEPT" recommendations** - all entries have specific terms or detailed explanations
✅ **All recommendations include evidence reasoning**
✅ **Reproducible curation methodology** established with documented scripts
✅ **User-driven quality improvements** throughout the process

---

## Lessons Learned

1. **User feedback is critical** - User identified the ACCEPT entry flaw that would have been missed
2. **Evidence codes matter** - Understanding NAS vs. IEA vs. IDA is crucial for annotation quality
3. **General knowledge vs. experimental evidence** - Many GO assignments rely on protein family knowledge rather than specific paper evidence
4. **Multifunctional proteins are challenging** - Single GO term may not capture full protein capability
5. **ERAD components often misannotated** - E3 ligases, lectins, and dislocation factors incorrectly called chaperones
6. **Documentation importance** - Detailed explanations essential for future curators to understand decisions
7. **Iterative refinement works** - Multiple phases with user feedback led to high-quality outcomes

---

**Document Created**: March 4, 2026
**Project Duration**: February 20 - March 4, 2026 (13 days)
**Total Annotations Curated**: 266
**Final Completion Rate**: 100% with justifications
